LISATA THERAPEUTICS, INC. Net Income (Loss) Attributable to Noncontrolling Interest
LISATA THERAPEUTICS, INC. (LSTA) reported Net Income (Loss) Attributable to Noncontrolling Interest of $141.26 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-11.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2012-05-11
- LISATA THERAPEUTICS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2012-03-31 was $141.26K, a 70.15% decline year-over-year.
- LISATA THERAPEUTICS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2011-12-31 was -$10.01M.
- LISATA THERAPEUTICS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2011-09-30 was $17.97K, a 98.43% decline year-over-year.
- LISATA THERAPEUTICS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2011-06-30 was $67.88K, a 95.79% decline year-over-year.
- LISATA THERAPEUTICS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2011 was -$9.45M, a 341.73% decline from fiscal 2010.
- LISATA THERAPEUTICS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2010 was $3.91M.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2012-03-31 | $141.26K 10-Q · filed 2012-05-11 | -$9.87M derived: sum of 2 quarters · filed 2012-05-11 | -$9.85M derived: sum of 3 quarters · filed 2012-05-11 | -$9.78M derived: sum of 4 quarters · filed 2012-05-11 |
| 2011-12-31 | -$10.01M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-20 | -$9.99M derived: sum of 2 quarters · filed 2012-03-20 | -$9.92M derived: sum of 3 quarters · filed 2012-03-20 | -$9.45M 10-K · filed 2012-03-20 |
| 2011-09-30 | $17.97K 10-Q · filed 2011-11-10 | $85.85K derived: sum of 2 quarters · filed 2011-11-10 | $559.08K 10-Q · filed 2011-11-10 | $382.03K derived: sum of 4 quarters · filed 2012-05-11 |
| 2011-06-30 | $67.88K 10-Q · filed 2011-08-12 | $541.11K 10-Q · filed 2011-08-12 | $364.06K derived: sum of 3 quarters · filed 2012-05-11 | $1.51M derived: sum of 4 quarters · filed 2012-05-11 |
| 2011-03-31 | $473.23K 10-Q · filed 2012-05-11 | $296.18K derived: sum of 2 quarters · filed 2012-05-11 | $1.44M derived: sum of 3 quarters · filed 2012-05-11 | $3.05M derived: sum of 4 quarters · filed 2012-05-11 |
| 2010-12-31 | -$177.05K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-20 | $968.53K derived: sum of 2 quarters · filed 2012-03-20 | $2.58M derived: sum of 3 quarters · filed 2012-03-20 | $3.91M 10-K · filed 2012-03-20 |
| 2010-09-30 | $1.15M 10-Q · filed 2011-11-10 | $2.76M derived: sum of 2 quarters · filed 2011-11-10 | $4.09M 10-Q · filed 2011-11-10 | |
| 2010-06-30 | $1.61M 10-Q · filed 2011-08-12 | $2.94M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |